1. Dessinioti C et al: A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes. Exp Dermatol 18:741-749, 2009
2. Dell'Angelica
EC et al: Lysosome-related organelles.
Faseb J 14:1265-1278, 2000
3. Van Den Bossche K, Naeyaert JM, Lambert J: The quest for the mechanism of melanin transfer. Traffic 7:769-778, 2006
4. Mancini AJ, Chan LS, Paller AS: Partial albinism with immunodeficiency: Griscelli syndrome: Report of a case and review of the literature. J Am Acad Dermatol 38:295-300, 1998
6. Goud B: How Rab proteins link motors to membranes. Nat Cell Biol 4:E77-E78, 2002
7. Van Gele M, Dynoodt P, Lambert J: Griscelli syndrome: A model system to study vesicular trafficking. Pigment Cell Melanoma Res 22:268-282, 2009
8. Klein C et al: Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr 125:886-895, 1994
9. Tezcan I et al: Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement. Bone Marrow Transplant 24:931-933, 1999
10. Schuster F et al: Griscelli syndrome: Report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant 28:409-412, 2001
11. Rossi A et al: Griscelli syndrome type 2: Long-term follow-up after unrelated donor bone marrow transplantation. Dermatology 218:376-379, 2009
12. Scheinfeld N, Johnson A: Griscelli syndrome. http://emedecine.medscape.com/article/1069442-overview, accessed. Aug 25, 2011
13. Griscelli C et al: A syndrome associating partial albinism and immunodeficiency. Am J Med 65:691-702, 1978
14. Mercer JA et al: Novel myosin heavy chain encoded by murine dilute coat colour locus. Nature 349:709-713, 1991
15. Menasche G et al: Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 112:450-456, 2003
16. Wilson SM et al: A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci U S A 97:7933-7938, 2000
17. Westbroek W et al: Rab27b is up-regulated in human Griscelli syndrome type II melanocytes and linked to the actin cytoskeleton via exon F-Myosin
Va transcripts.
Pigment Cell Res 17:498-505, 2004
18. Westbroek W et al: A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome. Mol Genet Metab 94:248-254, 2008
19. Westbroek W et al: Interactions of human Myosin
Va isoforms, endogenously expressed in human melanocytes, are tightly regulated by the tail domain.
J Invest Dermatol 120:465-475, 2003
20. Matesic LE et al: Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice. Proc Natl Acad Sci U S A 98:10238-10243, 2001
21. Cahali JB et al: Elejalde syndrome: Report of a case and review of the literature. Pediatr Dermatol 21:479-482, 2004
22. Afifi HH et al: Elejalde syndrome: Clinical and histopathological findings in an Egyptian male. Genet Couns 18:179-188, 2007
23. Duran-McKinster C et al: Elejalde syndrome—a melanolysosomal neurocutaneous syndrome: Clinical and morphological findings in 7 patients. Arch Dermatol 135:182-186, 1999
24. Lambert J, Vancoillie G, Naeyaert JM: Elejalde syndrome revisited. Arch Dermatol 136:120-121, 2000
25. Sanal O et al: An allelic variant of Griscelli disease: Presentation with severe hypotonia, mental-motor retardation, and hypopigmentation consistent with Elejalde syndrome (neuroectodermal melanolysosomal disorder). J Neurol 247:570-572, 2000
26. Bahadoran P et al: Comment on Elejalde syndrome and relationship with Griscelli syndrome. Am J Med Genet A 116A:408-409, 2003
27. Lang SK, Hort W, Mayser P: Differentially expressed genes associated with tryptophan-dependent pigment synthesis in Malassezia furfur—a comparison with the recently published genome of Malassezia globosa. Mycoses 54(4):e69-83, 2011
28. Crespo-Erchiga V, Florencio VD: Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 19:139-147, 2006
29. Gupta AK et al: Skin diseases associated with Malassezia species. J Am Acad Dermatol 51:785-798, 2004
30. James WD, Carter JM, Rodman OG: Pigmentary demarcation lines: A population survey. J Am Acad Dermatol 16:584-590, 1987
31. Krivo JM: How common is pigmentary mosaicism? Arch Dermatol 133:527-528, 1997
32. Maleville J, Taieb A: Pigmentary demarcation lines as markers of neural development. Arch Dermatol 133:1459, 1997
33. In SI et al: Clinical and histopathological characteristics of pityriasis alba. Clin Exp Dermatol 34:591-597, 2009
34. Di Lernia V, Ricci C: Progressive and extensive hypomelanosis and extensive pityriasis alba: Same disease, different names? J Eur Acad Dermatol Venereol 19:370-372, 2005
35. Blessmann Weber M et al: Pityriasis alba: A study of pathogenic factors. J Eur Acad Dermatol Venereol 16:463-468, 2002
36. Lin RL, Janniger CK: Pityriasis alba. Cutis 76:21-24, 2005
37. Nagaraja et al: Frequency and significance of minor clinical features in various age-related subgroups of atopic dermatitis in children. Pediatr Dermatol 13:10-13, 1996
38. Thoma W, Kramer HJ, Mayser P: Pityriasis versicolor alba. J Eur Acad Dermatol Venereol 19:147-152, 2005
39. Mashek H, Kalb R: Hypopigmentation of the extremities. Arch Dermatol 134:744-745, 747, 1998
40. Alexis JB: Sarcoidosis presenting as cutaneous hypopigmentation with repeatedly negative skin biopsies. Int J Dermatol 33:44-45, 1994
41. Mitchell IC et al: Ulcerative and hypopigmented sarcoidosis. J Am Acad Dermatol 15:1062-1065, 1986
42. Bonifati C et al: Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol 20:63-65, 2006
43. Ee HL, Tan SH: Reticulate hyperpigmented scleroderma: A new pigmentary manifestation. Clin Exp Dermatol 30:131-133, 2005
44. Soylu S et al: An uncommon presentation of the co-existence of morphea and vitiligo in a patient with chronic hepatitis B virus infection: Is there a possible association with autoimmunity? Am J Clin Dermatol 10:336-338, 2009
45. Johnson H et al: Chronic cutaneous lupus erythematosus in vitiligo. Dermatol Online J 14:10, 2008
46. Nath SK et al: Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 69:1401-1406, 2001
47. El-Darouti MA et al: Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis). Eur J Dermatol 16:17-22, 2006
48. El-Shabrawi-Caelen L et al: Hypopigmented mycosis fungoides: Frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 26:450-457, 2002
49. Gulekon A et al: Hypopigmented mycosis fungoides in an adolescent Turkish boy. Int J Dermatol 44:795-796, 2005
50. Stone ML et al: Hypopigmented mycosis fungoides: A report of 7 cases and review of the literature. Cutis 67:133-138, 2001
51. Ngo JT, Trotter MJ, Haber RM: Juvenile-onset hypopigmented mycosis fungoides mimicking vitiligo. J Cutan Med Surg 13:230-233, 2009
52. Farnsworth N, Rosen T: Endemic treponematosis: Review and update. Clin Dermatol 24:181-190, 2006
53. Enk CD: Onchocerciasis–river blindness. Clin Dermatol 24:176-180, 2006
54. Rathi SK et al: Post-kala-azar dermal leishmaniasis: A histopathological study. Indian J Dermatol Venereol Leprol 71:250-253, 2005
55. Zijlstra EE et al: Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3:87-98, 2003
56. Ramos-e-Silva M, Rebello PF: Leprosy. Recognition and treatment. Am J Clin Dermatol 2:203-211, 2001
57. Lerner EA, Sober AJ: Chemical and pharmacologic agents that cause hyperpigmentation or hypopigmentation of the skin. Dermatol Clin 6:327-337, 1988
58. English JS, Dawe RS, Ferguson J: Environmental effects and skin disease. Br Med Bull 68:129-142, 2003
59. Briganti S, Camera E, Picardo M: Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16:101-110, 2003
60. Perez-Bernal A, Munoz-Perez MA, Camacho F: Management of facial hyperpigmentation. Am J Clin Dermatol 1:261-268, 2000
61. Engasser PG, Maibach HI: Cosmetic and dermatology: Bleaching creams. J Am Acad Dermatol 5:143-147, 1981
62. Lacour JP: Physical agents causing hypomelanosis. In: The Pigmentary System: Physiology and Pathophysiology, edited by JJ Nordlund, RE Boissy, VJ Hearing, RA King, WS Oetting, JP Ortonne.. Oxford, Blackwell Publishing, 2006, pp. 683-685
63. Brochez L, Boone B, Naeyaert JM: Hypomelanoses associated with melanocytic neoplasia. In: The Pigmentary System: Physiology and Pathophysiology, 2nd edition, edited by JJ Nordlund, RE Boissy, VJ Hearing, RA King, WS Oetting, JP Ortonne. Oxford, Blackwell Publishing Ltd, 2006, pp. 705-724
64. Michelsen D: The Double strike hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma. Med Hypotheses 74:67-70, 2010
65. Jabbour SA: Cutaneous manifestations of endocrine disorders: A guide for dermatologists. Am J Clin Dermatol 4:315-331, 2003
66. Feingold KR, Elias PM: Endocrine-skin interactions. Cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders, and diabetes. J Am Acad Dermatol 17:921-940, 1987
67. Artantas S et al: Skin findings in thyroid diseases. Eur J Intern Med 20:158-161, 2009
68. Kohn FM, Ring J, Schill WB: [Dermatologic aspects of male hypogonadism]. Hautarzt 51:223-230, 2000
69. Vinton NE et al: Macrocytosis and pseudoalbinism: Manifestations of
selenium deficiency.
J Pediatr 111:711-717, 1987
70. Olivares M, Uauy R:
Copper as an essential nutrient.
Am J Clin Nutr 63:791S-796S, 1996
71. Wallace ML et al: Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol 25:375-379, 1998
72. Kumarasinghe SPW: 3–5 second cryotherapy is effective in idiopathic guttate hypomelanosis. J Dermatol 31:437-439, 2004
73. Hexsel DM: Treatment of idiopathic guttate hypomelanosis by localized superficial dermabrasion. Dermatol Surg 25:917-918, 1999
74. Falabella R et al: Leukoderma Punctata. J Am Acad Dermatol 18:485-494, 1988
75. Park JH, Lee MH: Case of leukoderma punctata after topical PUVA treatment. Int J Dermatol 43:138-139, 2004
76. Tobin DJ, Paus R: Graying: Gerontobiology of the hair follicle pigmentary unit. Exp Gerontol 36:29-54, 2001
77. Vogt A, Blume-Peytavi U: Biology of the human hair follicle. New insights and their clinical significance. Hautarzt 54(8):692-698, 2003
78. Commo S, Gaillard O, Bernard BA: Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. Br J Dermatol 150:435-443, 2004
79. Van Neste D, Tobin DJ: Hair cycle and hair pigmentation: Dynamic interactions and changes associated with aging. Micron 35:193-200, 2004
80. Westerhof W et al: Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol 140:210-214, 2004
81. Bessis D et al: Diffuse Bier white spots revealing cryoglobulinaemia. Br J Dermatol 146:921-922, 2002
82. Heller M: Diffuse Bier spots. Dermatol Online J 11:2, 2005
83. Braun RP et al: Dermoscopy of pigmented skin lesions. J Am Acad Dermatol 52:109-121, 2005
84. Reisfeld PL: Blue in the skin. J Am Acad Dermatol 42:597-605, 2000
85. Schievink WI et al: A familial syndrome of arterial dissections with lentiginosis. N Engl J Med 332:576-579, 1995
86. Betts CM et al: Progressive hyperpigmentation—Case-report with a clinical, histological, and ultrastructural investigation. Dermatology 189:384-391, 1994
87. Wang ZQ et al: Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation. Am J Hum Genet 84:672-677, 2009
88. Zanardo L et al: Progressive hyperpigmentation and generalized lentiginosis without associated systemic symptoms: A rare hereditary pigmentation disorder in south-east Germany. Acta Derm Venereol 84:57-60, 2004
89. Kalter DC, Griffiths WA, Atherton DJ: Linear and whorled nevoid hypermelanosis. J Am Acad Dermatol 19:1037-1044, 1988
90. Happle R: [Patterns on the skin. New aspects of their embryologic and genetic causes]. Hautarzt 55:960-961, 964-968, 2004
91. Hartmann A et al: Postnatal confirmation of prenatally diagnosed trisomy 20 mosaicism in a patient with linear and whorled nevoid hypermelanosis. Pediatr Dermatol 21:636-641, 2004
92. Delaporte E et al: Linear and whorled nevoid hypermelanosis versus incontinentia pigmenti: Is pigmentary incontinence really a distinctive feature? Dermatology 192:70-72, 1996
93. Taibjee SM, Bennett DC, Moss C: Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: The role of pigmentary genes. Br J Dermatol 151:269-282, 2004
94. Happle R: A fresh look at incontinentia pigmenti. Arch Dermatol 139:1206-1208, 2003
95. Fusco F et al: Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappa B activation. Hum Mol Genet 13:1763-1773, 2004
96. Makris C et al: Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 5:969-979, 2000
97. Hadj-Rabia S et al: Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol 139:1163-1170, 2003
98. Zillikens D et al: Hypopigmented and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol 13:57-62, 1991
99. Jessup CJ et al: Incontinentia pigmenti: Treatment of IP with topical
tacrolimus.
J Drugs Dermatol 8:944-946, 2009
100. Kaya TI, Tursen U, Ikizoglu G: Therapeutic use of topical corticosteroids in the vesiculobullous lesions of incontinentia pigmenti. Clin Exp Dermatol 34:e611-e613, 2009
101. Mitchell JR, Wood E, Collins K: A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551-555, 1999
102. Vulliamy T et al: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432-435, 2001
103. Vulliamy TJ et al: Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 27:353-357, 2001
104. Walne AJ, Dokal I: Advances in the understanding of dyskeratosis congenita. Br J Haematol 145:164-172, 2009
105. Lugassy J et al: Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: Two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am J Hum Genet 79:724-730, 2006
106. Porter RM, Lane EB: Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 19:278-285, 2003
107. Rycroft RJ, Calnan CD, Allenby CF: Dermatopathia pigmentosa reticularis. Clin Exp Dermatol 2:39-44, 1977
108. Degos R, Ossipowski B: [Reticulated pigmentary dermatosis of the folds: Relation to acanthosis nigricans.]. Ann Dermatol Syphiligr (Paris) 81:147-151, 1954
109. Betz RC et al: Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am J Hum Genet 78:510-519, 2006
110. Muller CS, Pfohler C, Tilgen W: Changing a concept–controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol 36:44-48, 2009
111. Zembowicz A, Mihm MC: Dermal dendritic melanocytic proliferations: An update. Histopathology 45:433-451, 2004
112. Ota M: Naevus fusco-caeruleus ophthalmo-maxillaris. Jpn J Dermatol 46:369, 1939
113. Park JH, Lee MH: Acquired, bilateral nevus of Ota-like macules (ABNOM) associated with Ota's nevus: Case report. J Korean Med Sci 19:616-618, 2004
114. Patel BC et al: Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): Report of a case and review of the literature. J Am Acad Dermatol 38:862-865, 1998
115. Balmaceda CM et al: Nevus of Ota and leptomeningeal melanocytic lesions. Neurology 43:381-386, 1993
116. Sinha S, Cohen PJ, Schwartz RA: Nevus of Ota in children. Cutis 82:25-29, 2008
117. Ito M: Naevus fusco-caeruleus acromio-deltoides. Tohuku Exp Med 60:10-12, 1954
118. Cordova A: The Mongolian spot: A study of ethnic differences and a literature review. Clin Pediatr (Phila) 20:714-719, 1981
119. Leung AK: Mongolian spots in Chinese children. Int J Dermatol 27:106-108, 1988
120. Leung AK, Kao CP, Leung AA: Persistent mongolian spots in Chinese adults. Int J Dermatol 44:43-45, 2005
121. Ashrafi MR et al: Extensive mongolian spots: A clinical sign merits special attention. Pediatr Neurol 34:143-145, 2006
122. Snow TM: Mongolian spots in the newborn: Do they mean anything? Neonatal Netw 24:31-33, 2005
123. Burkhart CG, Gohara A: Dermal melanocyte hamartoma. A distinctive new form of dermal melanocytosis. Arch Dermatol 117:102-104, 1981
124. Stratakis CA: Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. Front Biosci 5:D353-D366, 2000
125. Jeghers H, Mc Kusick V, Katz KH: Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits a syndrome of diagnostic significance. N Engl J Med 241:1031-1036, 1949
126. Jenne DE et al: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38-43, 1998
127. Digilio MC et al: LEOPARD syndrome: Clinical diagnosis in the first year of life. Am J Med Genet A 140:740-746, 2006
128. Sarkozy A, Digilio MC, Dallapiccola B: Leopard syndrome. Orphanet J Rare Dis 3:13, 2008
129. Carney JA et al: The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64:270-283, 1985
130. Boikos SA, Stratakis CA: Carney complex: Pathology and molecular genetics. Neuroendocrinology 83:189-199, 2006
131. Mateus C et al: Heterogeneity of skin manifestations in patients with Carney complex. J Am Acad Dermatol 59:801-810, 2008
132. Stratakis CA: Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas” (Carney complex). Ann N Y Acad Sci 968:3-21, 2002
133. Gorlin RJ et al: Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 44:307-314, 1992
134. Erkek E et al: Clinical and histopathological findings in Bannayan-Riley-Ruvalcaba syndrome. J Am Acad Dermatol 53:639-643, 2005
135. Hobert JA, Eng C: PTEN hamartoma tumor syndrome: An overview. Genet Med 11:687-694, 2009
136. Dociu I et al: Centrofacial lentiginosis. A survey of 40 cases. Br J Dermatol 94:39-43, 1976
137. Alper JC, Holmes LB: The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol 1:58-68, 1983
138. Rauen KA et al: Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A 152A:4-24, 2010
139. De Schepper S et al: Pigment cell-related manifestations in neurofibromatosis type 1: An overview. Pigment Cell Res 18:13-24, 2005
140. De Schepper S et al: Cafe-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: Hyperpigmentation of a different kind? Arch Dermatol Res 297:439-449, 2006
141. McCune DJ: Osteitis fibrosa cystica: The case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743-747, 1936
142. Albright F et al: Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: Reports of five cases. N Engl J Med 216:727-746, 1937
143. Ringel MD, Schwindinger WF, Levine MA: Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine (Baltimore) 75:171-184, 1996
144. Kaneko H, Kondo N: Clinical features of Bloom syndrome and function of the causative gene, BLM helicase. Expert Rev Mol Diagn 4:393-401, 2004
145. Cheok CF et al: Roles of the Bloom's syndrome helicase in the maintenance of genome stability. Biochem Soc Trans 33:1456-1459, 2005
146. Ellis NA, German J: Molecular genetics of Bloom's syndrome. Hum Mol Genet 5 Spec No:1457-1463, 1996
147. Watson GH: Pulmonary stenosis, cafe-au-lait spots, and dull intelligence. Arch Dis Child 42:303-307, 1967
148. Allanson JE et al: Watson syndrome: Is it a subtype of type 1 neurofibromatosis? J Med Genet 28:752-756, 1991
149.
Silver HK et al: Syndrome of congenital hemihypertrophy, shortness of stature and elevated urniary gonadotrophins.
Pediatrics 12:386-376, 1953
150. Russel A: A syndrome of “intra-uterine” dwarfism recognizable at birth with cranifacial dystosis. Proc R Soc Med 47:1040-1044, 1954
151. Hitchins MP et al: Silver-Russell syndrome: A dissection of the genetic aetiology and candidate chromosomal regions. J Med Genet 38:810-819, 2001
152. Schonherr N et al: (Epi)mutations in 11p15 significantly contribute to Silver-Russell syndrome: But are they generally involved in growth retardation? Eur J Med Genet 46(5):414-418, 2006
153. Abu-Amero S et al: The genetic aetiology of Silver-Russell syndrome. J Med Genet 45:193-199, 2008
154. Rossignol S et al: Epigenetics in Silver-Russell syndrome. Best Pract Res Clin Endocrinol Metab 22:403-414, 2008
155. Penaherrera MS et al: Methylation profiling in individuals with Russell-Silver syndrome. Am J Med Genet A 152A:347-355,
156. Roma P, Sanjeev H, Bhusan K: Generalized naevus spilus: A rare entity? J Eur Acad Dermatol Venereol 14:430, 2000
157. Kendereski A et al: White Addison's disease: What is the possible cause? J Endocrinol Invest 22:395-400, 1999
158. Slominski A et al: Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155-1228, 2004
159. Abdel-Malek Z et al: The melanocortin-1 receptor and human pigmentation. Ann N Y Acad Sci 885:117-133, 1999
160. Pereira MA et al: A study of patients with Nelson's syndrome. Clin Endocrinol (Oxf) 49:533-539, 1998
161. Zawar VP, Walvekar R: A pheochromocytoma presenting as generalized pigmentation. Int J Dermatol 43:140-142, 2004
162. Heymann WR: Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 26:885-902, 1992
163. Ai J, Leonhardt JM, Heymann WR: Autoimmune thyroid diseases: Etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol 48:641-159 quiz 660-662, 2003
164. Banba K et al: Hyperpigmentation caused by hyperthyroidism: Differences from the pigmentation of Addison's disease. Clin Exp Dermatol 24:196-198, 1999
165. Victor FC, Gelber J, Rao B: Melasma: A review. J Cutan Med Surg 8:97-102, 2004
166. Ting PT, Barankin B: Can you identify this condition? Melasma. Can Fam Physician 51:353-355, 2005
167. Costin GE, Birlea SA: What is the mechanism for melasma that so commonly accompanies human pregnancy? IUBMB Life 58:55-57, 2006
168. Nussbaum R, Benedetto AV: Cosmetic aspects of pregnancy. Clin Dermatol 24:133-141, 2006
169. Elling SV, Powell FC: Physiological changes in the skin during pregnancy. Clin Dermatol 15:35-43, 1997
170. Buno IJ, Morelli JG, Weston WL: The enamel paint sign in the dermatologic diagnosis of early-onset Kwashiorkor. Arch Dermatol 134:107-108, 1998
171. Mori K, Ando I, Kukita A: Generalized hyperpigmentation of the skin due to vitamin B12 deficiency. J Dermatol 28:282-285, 2001
172. Lechner K et al: [Vitamin B12 deficiency. New data on an old theme]. Wien Klin Wochenschr 117:579-591, 2005
173. Egli F, Walter R: Images in clinical medicine. Vitiligo and pernicious anemia. N Engl J Med 350:2698, 2004
174. Sabatino D et al: Cobalamin deficiency presenting with cutaneous hyperpigmentation: A report of two siblings. Pediatr Hematol Oncol 15:447-450, 1998
175. Volkov I, Press Y, Rudoy I: Vitamin B12 could be a “master key” in the regulation of multiple pathological processes. J Nippon Med Sch 73:65-69, 2006
176. Downham TF II, Rehbein HM, Taylor KE: Letter: Hyperpigmentation and folate deficiency. Arch Dermatol 112:562, 1976
177. MacDonald A, Forsyth A: Nutritional deficiencies and the skin. Clin Exp Dermatol 30:388-390, 2005
178. Brandhagen DJ, Fairbanks VF, Baldus W: Recognition and management of hereditary hemochromatosis. Am Fam Physician 65:853-860, 2002
179. Stulberg DL, Clark N, Tovey D: Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation. Am Fam Physician 68:1963-1968, 2003
180. Waalen J, Nordestgaard BG, Beutler E: The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 18:203-220, 2005
181. Kostler E, Porst H, Wollina U: Cutaneous manifestations of metabolic diseases: Uncommon presentations. Clin Dermatol 23:457-464, 2005
182. Goldblatt J, Beighton P: Cutaneous manifestations of Gaucher disease. Br J Dermatol 111:331-334, 1984
183. Busam KJ, et al: Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma. J Cutan Pathol 31:274-280, 2004
184. Mitsuhashi K, Miyashita T: [Treatment of so-called keloid with excision and postoperative electron irradiation]. Nippon Ika Daigaku Zasshi 62:186-195, 1995
185. Quinlan KE et al: Transverse melanonychia secondary to total skin electron beam therapy: A report of 3 cases. J Am Acad Dermatol 53:S112-S114, 2005
186. Peter RU et al: Chronic cutaneous damage after accidental exposure to ionizing radiation: The Chernobyl experience. J Am Acad Dermatol 30:719-723, 1994
187. Manning MA et al: Interstitial high-dose-rate brachytherapy boost: The feasibility and cosmetic outcome of a fractionated outpatient delivery scheme. Int J Radiat Oncol Biol Phys 48:1301-1306, 2000
188. Steinert M et al: Delayed effects of accidental cutaneous radiation exposure: Fifteen years of follow-up after the Chernobyl accident. J Am Acad Dermatol 49:417-423, 2003
189. Peter RU et al: Radiation lentigo. A distinct cutaneous lesion after accidental radiation exposure. Arch Dermatol 133:209-211, 1997
190. de Chalain TM, Tang C, Thomson HG: Burn area color changes after superficial burns in childhood: Can they be predicted? J Burn Care Rehabil 19:39-49, 1998
191. Zouboulis CC: Cryosurgery in dermatology. Eur J Dermatol 8:466-474, 1998
192. Kelly KM, Svaasand LO, Nelson JS: Further investigation of pigmentary changes after alexandrite laser hair removal in conjunction with cryogen spray cooling. Dermatol Surg 30:581-582, 2004
193. Tanzi EL, Lupton JR, Alster TS: Lasers in dermatology: Four decades of progress. J Am Acad Dermatol 49:1-31 quiz 31-34, 2003
194. Al-Aboosi M et al: Friction melanosis: A clinical, histologic, and ultrastructural study in Jordanian patients. Int J Dermatol 43:261-264, 2004
195. Dereure O: Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2:253-262, 2001
196. Levin CY, Maibach H: Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol 2:213-217, 2001
197. Dereure O et al: [Cutaneous lesions in POEMS syndrome. Apropos of 3 case reports and a review of the literature]. Ann Dermatol Venereol 117:283-290, 1990
198. Shelley WB, Shelley ED: The skin changes in the Crow-Fukase (POEMS) syndrome. A case report. Arch Dermatol 123:85-87, 1987
199. Haas N, Vogt R, Sterry W: [Shiitake dermatitis: Flagellate dermatitis after eating mushrooms]. Hautarzt 52:132-135, 2001
200. Mowad CM et al: Bleomycin-induced flagellate dermatitis: A clinical and histopathological review. Br J Dermatol 131:700-702, 1994
201. Nakamura T: Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis 27:65-70, 1992
202. Bendick C, Rasokat H, Steigleder GK: Azidothymidine-induced hyperpigmentation of skin and nails. Arch Dermatol 125:1285-1286, 1989
203. Greenberg RG, Berger TG: Nail and mucocutaneous hyperpigmentation with azidothymidine therapy. J Am Acad Dermatol 22:327-330, 1990
204. Bilic M, Adams BB: Erythema ab igne induced by a laptop computer. J Am Acad Dermatol 50:973-974, 2004
205. Page EH, Shear NH: Temperature-dependent skin disorders. J Am Acad Dermatol 18:1003-1019, 1988
206. Tan S, Bertucci V: Erythema ab igne: An old condition new again. CMAJ 162:77-78, 2000
207. Boer A et al: Prurigo pigmentosa: A distinctive inflammatory disease of the skin. Am J Dermatopathol 25:117-129, 2003
208. Hori Y et al: Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 10:961-964, 1984
209. Ee HL et al: Characteristics of Hori naevus: A prospective analysis. Br J Dermatol 154:50-53, 2006
210. Park JM, Tsao H, Tsao S: Acquired bilateral nevus of Ota-like macules (Hori nevus): Etiologic and therapeutic considerations. J Am Acad Dermatol 61:88-93, 2009
211. Mizoguchi M et al: Clinical, pathological, and etiologic aspects of acquired dermal melanocytosis. Pigment Cell Res 10:176-183, 1997
212. Hidano A, Kaneko K: Acquired dermal melanocytosis of the face and extremities. Br J Dermatol 124:96-99, 1991
213. Sun CC et al: Naevus fusco-caeruleus zygomaticus. Br J Dermatol 117:545-553, 1987
214. Murakami F, Soma Y, Mizoguchi M: Acquired symmetrical dermal melanocytosis (naevus of Hori) developing after aggravated atopic dermatitis. Br J Dermatol 152:903-908, 2005
215. Choi JE et al: Treatment of Becker's nevi with a long-pulse alexandrite laser. Dermatol Surg 35:1105-1108, 2009
216. Danarti R et al: Becker's nevus syndrome revisited. J Am Acad Dermatol 51:965-969, 2004
217. Happle R: Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 129:1460-1470, 1993
218. Lambert JR et al: Becker's nevus associated with chromosomal mosaicism and congenital adrenal hyperplasia. J Am Acad Dermatol 30:655-657, 1994
219. Lacz NL et al: Postinflammatory hyperpigmentation: A common but troubling condition. Int J Dermatol 43:362-365, 2004
220. Katz TM et al: Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation. Dermatol Surg 35:1844-1848, 2009
221. Grimes PE: Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg 28:77-85, 2009
222. Taylor S et al: Postinflammatory hyperpigmentation. J Cutan Med Surg 13:183-191, 2009
223. Goodman RM, Belcher RW: Periorbital hyperpigmentation. An overlooked genetic disorder of pigmentation. Arch Dermatol 100:169-174, 1969
224. Pique E et al: Partial unilateral lentiginosis: Report of seven cases and review of the literature. Clin Exp Dermatol 20:319-322, 1995
225. Rongioletti F, Rebora A: Acquired brachial cutaneous dyschromatosis: A common pigmentary disorder of the arm in middle-aged women. J Am Acad Dermatol 42:680-684, 2000
226. Ebihara T, Nakayama H: Pigmented contact dermatitis. Clin Dermatol 15:593-599, 1997
227. Serrano G et al: Riehl's melanosis: Pigmented contact dermatitis caused by fragrances. J Am Acad Dermatol 21:1057-1060, 1989
228. Lampe AK et al: Laugier-Hunziker syndrome: An important differential diagnosis for Peutz-Jeghers syndrome. J Med Genet 40:e77, 2003
229. Sebbag N, Lacour JP: [Erythema dyschromicum perstans]. Ann Dermatol Venereol 133:79-82, 2006
230. Torrelo A et al: Erythema dyschromicum perstans in children: A report of 14 cases. J Eur Acad Dermatol Venereol 19:422-426, 2005
231. Correa MC et al: HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients. J Am Acad Dermatol 56:617-620, 2007
232. Sanz de Galdeano C et al: Idiopathic eruptive macular pigmentation: Report of five patients. Pediatr Dermatol 13:274-277, 1996
233. Sethuraman G et al: Dyschromatosis universalis hereditaria. Clin Exp Dermatol 27:477-479, 2002
234. Westerhof W et al: Hereditary congenital hypopigmented and hyperpigmented macules. Arch Dermatol 114:931-936, 1978
235. Grosshans E, Stoebner P, Basset A: [Leukomelanoderma of vagabonds. Anatomopathological and ultrastructural study]. Ann Dermatol Syphiligr (Paris) 99:141-159, 1972